The Food and Drug Administration on Wednesday approved COVID-19 vaccines under a more limited framework after rescinding the emergency use authorizations previously in place.
According to the manufacturers, the FDA approved the vaccines for everyone 65 and older, but limited their use to high-risk populations of a certain age for non-elderly patients. Moderna’s vaccine was approved for those at risk and age 6 months or older and Pfizer’s for those at risk aged 5 years or older.
Novavax had previously announced that its vaccine was approved for high-risk patients aged 12 and up.
